Publication sales decreased 11.23%, primarily as a result of lower unit sales. This decrease was due to the fact that Citem stopped distributing some publications that did not meet our minimal profitability requirements.
The sales mix did not change significantly this quarter. Private Pharma
sales represented 83.88% of total sales (compared to 83.27% during the
third quarter of 2007), while Government Pharma accounted for 3.83% (versus
3.46% during the third quarter of 2007). Health, Beauty, Consumer Goods,
General Merchandise and Other represented 9.20% (compared to 9.33% in the
third quarter of 2007) and Publications made up the remaining 3.09% (versus
3.94% during the third quarter of 2007).
SALES BY DIVISION
Sales in our Private Pharma division rose 13.89% during the third quarter of 2008, as a result of the consolidation of investments that were made within the sector during the past several months. This includes the most recent acquisition of Drogasmil Medicamento e Perfumeria, S.A., a Brazilian pharmacy chain.
Sales reached $5,604.89 million and represented 83.88% of the Group's total sales.
Sales in our Government Pharma division grew 25.13% due to an increase in sales to the Instituto Mexicano del Seguro Social ("IMSS") as well as the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado ("ISSSTE").
Government Pharma sales reached $256.13 million during 3Q08 and accounted for 3.83% of our total sales.
HEALTH, BEAUTY, CONSUMER GOODS, GENERAL MERCHANDISE AND OTHER
Sales in our Health, Beauty, Consumer Goods, General Merch
|SOURCE Grupo Casa Saba, S.A. de C.V.|
Copyright©2008 PR Newswire.
All rights reserved